Fate Therapeutics uses iPSC and gene editing to offer scalable off-the-shelf therapies. Read more to see why I rate FATE ...

More Than 20 Alpha Therapies Are In Clinical Trials Says KUICK RESEARCH In Recent PublicationDelhi, Jan. 29, 2025 (GLOBE ...

Freyr Battery (NYSE:FREY) has informed officials in a suburban Atlanta county that it won’t proceed with a $2.6B plant, the Newnan Times Herald reported Thursday. According to the report, the ...

With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, ...

Nuvectis is also advancing NXP900 for YES1/SRC-expressing solid tumors, with promising early data showing no dose-limiting ...

China Emerging Key Player in Development Of Gamma Delta T Cell Cancer Therapy Says KUICK RESEARCHDelhi, Jan. 29, 2025 (GLOBE ...

A recent study from the Earth-Life Science Institute (ELSI) investigates how polyester microdroplets, potential precursors to modern cells, could form under realistic early Earth conditions.

Understanding these risks is the first step toward creating a cleaner, safer future. Researchers make alarming new discovery while investigating side effects of cigarettes — here's what they found ...

Olive oil bioactives, including MUFAs, polyphenols, and triterpenoids, modulate gene expression linked to insulin sensitivity ...

AdvanCell has secured $112 million in a Sanofi Ventures-backed series C funding round as the Australian radiopharma company ...